Gut bacteria cocktail aims to tame liver failure
NCT ID NCT06871111
First seen Nov 05, 2025 · Last updated May 11, 2026 · Updated 31 times
Summary
This early-stage trial tests whether giving a mix of healthy gut bacteria (from donors) to people hospitalized with liver disease is safe and tolerable. The study involves 24 adults with liver failure or cirrhosis who have low levels of certain gut chemicals. Researchers will monitor side effects and check if the bacteria take hold in the gut over one year.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS, LIVER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The University of Chicago Medical Center
RECRUITINGChicago, Illinois, 60637, United States
Contact
Contact
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.